Brown, Lisle/Cummings’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.5K Hold
96
0.01% 371
2025
Q4
$44.9K Hold
96
0.01% 354
2025
Q3
$41K Hold
96
0.01% 362
2025
Q2
$36.8K Hold
96
0.01% 366
2025
Q1
$33.2K Buy
96
+1
+1% +$322 0.01% 367
2024
Q4
$28.5K Hold
95
0.01% 378
2024
Q3
$38.6K Hold
95
0.01% 339
2024
Q2
$30.5K Hold
95
0.01% 349
2024
Q1
$31.7K Hold
95
0.01% 334
2023
Q4
$25.7K Hold
95
0.01% 340
2023
Q3
$23.4K Hold
95
0.01% 321
2023
Q2
$28.8K Buy
+95
New +$26.4K 0.01% 307

Other funds holding HCA

Brown, Lisle/Cummings's HCA Position: Q1 2026 in Review

Brown, Lisle/Cummings held its HCA Healthcare (HCA) position steady in Q1 2026 at 96 shares worth $45.5K. The position accounts for 0.01% of the portfolio, ranked #371.

Brown, Lisle/Cummings first reported a position in HCA in Q2 2023 and has held it in 12 quarters since. 1,420 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Brown, Lisle/Cummings held 96 shares of HCA Healthcare worth $45.5K as of Q1 2026.
  • Brown, Lisle/Cummings left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #371 holding.
  • Brown, Lisle/Cummings first reported a position in HCA Healthcare in Q2 2023 and has held it in 12 quarters since.
  • 1,420 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.